All News #Library
Sciences
Urovant Sciences Initiates Pt Enrollment in Ph2a Clinical Trial for Vibegron
03 Jan 2019 //
BUSINESSWIRE
Overactive bladder biotech Urovant Sciences sets terms for $150 million IPO
17 Sep 2018 //
NASDAQ

Market Place
Sourcing Support